Hofseth Biocare ASA (HBC) — Cash Flow Reinvestment Rate
Hofseth Biocare ASA (HBC) has a Cash Flow Reinvestment Rate of 2.87x as of December 2024, reinvesting Nkr2.44 Million (capex Nkr1.22 Million plus investments Nkr-1.22 Million) from operating cash flow of Nkr851.00K. Explore HBC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hofseth Biocare ASA Cash Flow Reinvestment Rate (2015–2023)
Historical reinvestment intensity for Hofseth Biocare ASA across 2 annual periods. Also explore HBC total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hofseth Biocare ASA (2015–2023)
Year-by-year capital reinvestment analysis for Hofseth Biocare ASA. For live market cap and broader valuation context, see Hofseth Biocare ASA market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 9.51x | Nkr26.25 Million | Nkr2.76 Million | Nkr8.19 Million | ▲ +512.0% |
| 2015 | 1.55x | Nkr12.37 Million | Nkr7.97 Million | Nkr11.84 Million | — |